| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | BKUH | Common Stock | 87,555,453 | 31 Jul 2021 | Direct | F1 | |||||
| holding | BKUH | Series A Preferred Stock | 4 | 31 Jul 2021 | Cell Science Holding Ltd. | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | BKUH | Stock Option | 100,000 | 31 Jul 2021 | Common Stock | 100,000 | $5.10 | Direct |
| Id | Content |
|---|---|
| F1 | Consists of (a) 126,882 shares of Common Stock owned directly by Mr. Whitton and (b) 87,428,571 shares of Common Stock owned by Mentone Ltd. Mr. Whitton is the owner of 34% of Mention Ltd., and is deemed the beneficial owner of shares owned by Mention |
| F2 | Cell Science is owned by Inter-M Traders FZ LLC (40%), OZ Corporation (30%) and Mentone Ltd. (30%) Mr. Whitton is the owner of 34% of Mention Ltd., and is deemed to be the beneficial owner of the 4 shares of Series A Preferred Stock owned by Cell Science. |